Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Rochelle Naylor MD

Rochelle N. Naylor MD

Associate Professor of Pediatrics and Medicine, Section of Adult and Pediatric Endocrinology, Diabetes, & Metabolism, University of Chicago; Associate Program Director, Diversity, Equity, and Inclusion; The University of Chicago Pediatric Residency Training Program, Chicago, Illinois

Dr. Rochelle Naylor is an Associate Professor of Pediatrics with a secondary appointment in Medicine in the Section of Adult and Pediatric Endocrinology, Diabetes, and Metabolism at the University of Chicago.

Dr. Naylor’s clinical expertise and research interests are in genetic and atypical forms of diabetes. She is  a co-Investigator of the University of Chicago Monogenic Diabetes Registry where her work has addressed barriers to accurate genetic diagnosis of MODY and inequities in who benefits from diabetes precision medicine. She has carried out cost-effectiveness analyses demonstrating the economic value of diabetes precision medicine for MODY. She is also a co-Investigator of the rare and atypical diabetes network, or RADIANT study, aiming to identify new causes of diabetes and better understand the pathoetiology of type 2 diabetes. She additionally contributes to gene and variant curation efforts for monogenic diabetes through ClinGen and has contributed to the Precision Medicine in Diabetes Initiative of the ADA and EASD.

Disclosures

Dr. Naylor participated in the ADA/EASD Precision Medicine in Diabetes Initiative.